Intelligence · Clinical Development
Pipeline search results
Programs matching “Vertex Pharmaceuticals” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 159 pipeline programs matching "Vertex Pharmaceuticals" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
VX22-445-123
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VX24-AIS-D10
Vertex Pharmaceuticals (Australia) Pty.
Primary Membranous Nephropathy
1 trial -
ALPN-101
Vertex Pharmaceuticals (Australia) Pty.
Systemic Lupus Erythematosus
1 trial -
AVN944
Vertex Pharmaceuticals (Australia) Pty.
Pancreatic Cancer
1 trial -
CTX001-121
Vertex Pharmaceuticals (Australia) Pty.
Severe sickle cell disease (SCD)
1 trial -
Cethrin
Vertex Pharmaceuticals (Australia) Pty.
Spinal Cord Injury
1 trial -
Inaxaplin
Vertex Pharmaceuticals (Australia) Pty.
Proteinuric Kidney Disease
1 trial -
Ivacaftor
Vertex Pharmaceuticals (Australia) Pty.
Chronic Obstructive Pulmonary Disease
1 trial -
Ivacaftor 150 MG
Vertex Pharmaceuticals (Australia) Pty.
Chronic Obstructive Pulmonary Disease
1 trial -
Ivacaftor 25 mg/75 mg
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
MP-424 (Telaprevir)
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Merimepodib
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
P-1037
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Placebo
Vertex Pharmaceuticals (Australia) Pty.
Rheumatoid Arthritis
1 trial -
Placebo (matched to VX-121 suspension)
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Povetacicept
Vertex Pharmaceuticals (Australia) Pty.
Myasthenia Gravis, Generalized
1 trial -
Ribavirin
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Diabetic Peripheral Neuropathy
1 trial -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
Telaprevir and Sofosbuvir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C, Chronic
1 trial -
Tezacaftor/Ivacaftor + Ivacaftor
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
VC-02 Combination Product
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes Mellitus With Hypoglycemia
1 trial -
VCH-222 or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VCH-759 (BCH-27759)
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C, Chronic
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.